Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-α-induced hepatitis in mice
- 8 December 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 229 (1) , 63-67
- https://doi.org/10.1016/0014-2999(92)90286-d
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of the New 5-Lipoxygenase Inhibitor E6080 on Leukotriene Release in vitroInternational Archives of Allergy and Immunology, 1992
- Effect of a novel 5-lipoxygenase inhibitor, E6080 on bronchospasm, airway cellular infiltration and leukotriene production in guinea pigsProstaglandins, Leukotrienes & Essential Fatty Acids, 1991
- Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized miceHepatology, 1990
- Role of Endotoxin–Responsive Macrophages in Hepatic InjuryHepatology, 1990
- The role of thromboxane A2 [TxA2] in liver injury in miceProstaglandins, 1989
- The history, properties, and biological effects of cachectinBiochemistry, 1988
- Leukotriene-mediated liver injuryBiochemical Pharmacology, 1988
- The Relation of Leukotrienes to Liver InjuryHepatology, 1985
- Protective effects of 16,16-dimethyl PGE2 on the liver and kidneyProstaglandins, 1981
- TRANSAMINASE ACTIVITY IN HUMAN BLOODJournal of Clinical Investigation, 1955